The Hydration Pharmaceuticals Company Ltd (HPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.606x

Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has a cash flow conversion efficiency ratio of -0.606x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.64 Million ≈ $-1.16 Million USD) by net assets (AU$2.71 Million ≈ $1.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

The Hydration Pharmaceuticals Company Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how The Hydration Pharmaceuticals Company Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read HPC total debt and obligations for a breakdown of total debt and financial obligations.

The Hydration Pharmaceuticals Company Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Aker Horizons AS
OL:AKH
-0.007x
SPOTLITE360 IOT SOLUTIONS
F:87A0
N/A
Greencastle Resources Ltd.
V:VGN
-0.045x
Tarku Resources Ltd
V:TKU
-0.015x
Geneuro SA
PA:GNRO
0.393x
Teras Resources Inc
V:TRA
0.129x
Spectra Systems Corp
LSE:SPSY
-0.016x
River and Mercantile UK Micro Cap Investment Company Ltd
LSE:RMMC
-0.007x

Annual Cash Flow Conversion Efficiency for The Hydration Pharmaceuticals Company Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see how much is The Hydration Pharmaceuticals Company Lt worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$2.74 Million
≈ $1.94 Million
AU$-3.02 Million
≈ $-2.14 Million
-1.101x -106.89%
2023-12-31 AU$-358.25K
≈ $-253.49K
AU$-5.73 Million
≈ $-4.05 Million
15.993x +752.93%
2022-12-31 AU$3.98 Million
≈ $2.82 Million
AU$-9.75 Million
≈ $-6.90 Million
-2.449x -301.06%
2021-12-31 AU$13.23 Million
≈ $9.36 Million
AU$-8.08 Million
≈ $-5.72 Million
-0.611x +68.33%
2020-12-31 AU$2.00 Million
≈ $1.42 Million
AU$-3.86 Million
≈ $-2.73 Million
-1.928x -69.48%
2019-12-31 AU$2.44 Million
≈ $1.73 Million
AU$-2.78 Million
≈ $-1.97 Million
-1.138x +43.84%
2018-12-31 AU$2.66 Million
≈ $1.88 Million
AU$-5.40 Million
≈ $-3.82 Million
-2.026x --

About The Hydration Pharmaceuticals Company Ltd

AU:HPC Australia Food Distribution
Market Cap
$914.46K
AU$1.29 Million AUD
Market Cap Rank
#30268 Global
#1790 in Australia
Share Price
AU$0.00
Change (1 day)
-25.00%
52-Week Range
AU$0.00 - AU$0.02
All Time High
AU$0.36
About

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more